Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
DarioHealth Corp. (Nasdaq: DRIO) has published a new study in Frontiers in Endocrinology, demonstrating the effectiveness of its cardiometabolic solution for individuals with diabetes or prediabetes and depression. The research, involving 989 users over 12 months, reveals: Members with depression showed higher average blood glucose (BG) levels than those without Both groups experienced significant BG decreases in the first 4 months of platform usage A statistically significant association between depression status, BG levels, and average number of steps Monthly average steps fully mediate the association between self-reported depression and monthly average BG Users averaging over 400 steps daily showed significant decreases in monthly average BG
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more